G
GreenLab
Producing proteins with next-generation plant biotechnology in the factory of the future: the cornfield
About GreenLab
GreenLab is a pioneering company in the biotechnology sector, specializing in the production of next-generation proteins using innovative plant-based technology. The company primarily serves clients in the food, agriculture, and pharmaceutical industries, offering scalable solutions that meet growing market demands. GreenLab operates in the global biotechnology market, focusing on sustainable and cost-effective production methods. The business model revolves around optimizing and growing proteins directly inside corn kernels, eliminating the need for expensive fermentation facilities. This approach not only reduces upfront costs by $100 million but also drives greener production and minimizes overhead. GreenLab generates revenue through the direct sale of its proprietary protein products, leveraging its high accumulation rates and commercially viable implantation success rate of 96%. By producing proteins in cornfields, the company can scale production with minimal additional capital and infrastructure, ensuring just-in-time manufacturing capabilities. The stability of the protein in corn grain allows for flexible storage and refining processes, reducing inefficiencies and waste.
Source: Dealroom company dataAt a glance
- Founded
- 2006
- Headquarters
- Jonesboro, United States
- Sector
- Food
Knowledge graph
More headlines
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about GreenLab on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See GreenLab on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.